Healixa Inc.
EMOR · OTC
3/31/2024 | 3/31/2023 | 3/31/2022 | 3/31/2021 | |
|---|---|---|---|---|
| Market Cap | $108,191 | $140,053 | $719,062 | $1,255,685 |
| - Cash | $92 | $23 | $135 | $196 |
| + Debt | $6,596 | $5,603 | $3,232 | $510 |
| Enterprise Value | $114,695 | $145,633 | $722,160 | $1,255,998 |
| Revenue | $599 | $9 | $0 | $59 |
| % Growth | 6,688.5% | – | -100% | – |
| Gross Profit | $211 | -$24 | -$23 | -$50 |
| % Margin | 35.2% | -275.3% | – | -83.3% |
| EBITDA | -$6,320 | -$522 | -$2,596 | -$14,961 |
| % Margin | -1,055.4% | -5,916.8% | – | -25,166.4% |
| Net Income | -$6,730 | -$645 | -$2,843 | -$15,058 |
| % Margin | -1,123.8% | -7,316.1% | – | -25,329.4% |
| EPS Diluted | -0.009 | -0.001 | -0.004 | -0.019 |
| % Growth | -987.5% | 77.1% | 81.2% | – |
| Operating Cash Flow | -$879 | -$2,139 | -$1,694 | -$1,636 |
| Capital Expenditures | -$0 | $0 | -$115 | -$22 |
| Free Cash Flow | -$879 | -$2,139 | -$1,809 | -$1,657 |